Rapid reversal of parenteral-nutrition-associated cirrhosis following isolated intestinal transplantation

Journal of Gastrointestinal Surgery

Volumn 13, Issue 9, 2009, Pages 1717-1723

  Fiel, M Isabel ^a   Wu, Hai Shan ^a   Iyer, Kishore ^b   Rodriguez Laiz, Gonzalo ^b   Schiano, Thomas D ^a,b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

Cirrhosis; Hepatic fibrosis; Intestinal transplantation; TPN

Indexed keywords

ADULT; ALLOTRANSPLANTATION; ARTICLE; CASE REPORT; CHRONIC DISEASE; CONVALESCENCE; FOLLOW UP; GRAFT SURVIVAL; HOSPITALIZATION; HUMAN; IMMUNOHISTOCHEMISTRY; INTESTINE PSEUDOOBSTRUCTION; LIVER CIRRHOSIS; LIVER FUNCTION TEST; MALE; METHODOLOGY; NEEDLE BIOPSY; PATHOLOGY; PORTAL HYPERTENSION; POSTOPERATIVE PERIOD; SMALL INTESTINE; SPLENOMEGALY; TIME; TOTAL PARENTERAL NUTRITION; TRANSPLANTATION; TREATMENT OUTCOME;

ADULT; BIOPSY, NEEDLE; CHRONIC DISEASE; FOLLOW-UP STUDIES; GRAFT SURVIVAL; HUMANS; HYPERTENSION, PORTAL; IMMUNOHISTOCHEMISTRY; INTESTINAL PSEUDO-OBSTRUCTION; INTESTINE, SMALL; LIVER CIRRHOSIS; LIVER FUNCTION TESTS; MALE; PARENTERAL NUTRITION, TOTAL; POSTOPERATIVE PERIOD; RECOVERY OF FUNCTION; SEVERITY OF ILLNESS INDEX; SPLENOMEGALY; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 70349422260     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11605-009-0914-7     Document Type: Article

References (26)

1. Kelly DA. Intestinal failure-associated liver disease: what do we know today? Gastroenterology 2006;13:S70-S77. doi:10.1053/j.gastro.2005.10.066.
2. Buchman AL, Iyer K, Fryer J. Parenteral nutrition-liver disease and the role for isolated intestine and intestine/liver transplantation. Hepatology 2006;43:9-19. doi:10.1002/hep.20997.
3. Chan S, McCowen KC, Bistrian BR, et al. Incidence, prognosis, and etiology of end stage liver disease in patients receiving home parenteral nutrition. Surgery 1999;126:28-34. doi:10.1067/msy.1999.98925.
4. Cavicchi M, Beau P, Crenn P, et al. Prevalence of liver disease and contributing factors in patients receiving home parenteral nutrition for permanent intestinal failure. Ann Intern Med 2000;132:525-532.
5. Kumpf VJ. Parenteral nutrition-associated liver disease in adult and pediatric patients. Nutr Clin Pract 2006;21:279-290. doi:10.1177/0115426506021003279.
6. Fryer JP, Iyer K. Innovative approaches to improving organ availability for small bowel transplant candidates. Gastroenterology 2006;130:S152-S157. doi:10.1053/j.gastro.2005.10.064.
7. Luman W, Shaffer JL. Prevalence, outcome and associated factors of deranged liver function tests in patients on home parenteral nutrition. Clin Nutr 2002;21:337-343. doi:10.1054/clnu.2002.0554.
8. Fryer J, Pellar S, Ormond D, et al. Mortality in candidates waiting for combined liver-intestine transplants exceeds that for other candidates waiting for live transplants. Liver Transpl 2003;9:748-753. doi:10.1053/jlts.2003.50151.
9. Shiffman ML, Saab S, Feng S, et al. Liver and intestine transplantation in the United States, 1995-2004. Am J Transplant 2006;6:1170-1187. doi:10.1111/j.1600-6143.2006.01273.x.
10. Sudan DL, Kaufman SS, Shaw BW, et al. Isolated intestinal transplantation for intestinal failure. Am J Gastroenterol 2000;95:1506-1515. doi:10.1111/j.1572-0241.2000.02088.x.
11. Dufour JF, DeLellis R, Kaplan MM. Reversibility of hepatic fibrosis in autoimmune hepatitis. Ann Intern Med 1997;127:981-985.
12. Hammel P, Couvelard A, O'Toole D, Ratouis A, Sauvanet A, Flejou JF, et al. Regression of liver fibrosis after biliary drainage in patients with chronic pancreatitis and stenosis of the common bile duct. N Engl J Med 2001;344:418-423. doi:10.1056/NEJM200102083440604.
13. Muretto P, Angelucci E, Lucarelli G. Reversibility of cirrhosis in patients cured of thalassemia by bone marrow transplantation. Ann Intern Med 2002;136:667-672.
14. Kral JG, Thung SN, Biron S, Hould FS, Lebel S, Marceau S, et al. Effects of surgical treatment of the metabolic syndrome on liver fibrosis and cirrhosis. Surgery 2004;135:48-58. doi:10.1016/j.surg.2003.10.003.
15. Dienstag JL, Goldin RD, Heathcote EJ, Hann HW, Woessner M, Stephenson SL, et al. Histological outcome during long-term lamivudine therapy. Gastroenterology 2003;124:105-117. doi:10.1053/gast.2003.50013.
16. Poynard T, McHutchison J, Manns M, Trepo C, Lindsay K, Goodman Z, et al. Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C. Gastroenterology 2002;122:1303-1313. doi:10.1053/gast.2002.33023.
17. Crespo-Leiro MG, Robles O, Paniagua MJ, Marzoa R, Naya C, Flores X, Suarez F, Gomez M, Grille Z, Cuenca JJ, Castro-Beiras A, Arnal F. Reversal of cardiac cirrhosis following orthotopic heart transplantation. Am J Transplant 2008;8:1336-1339. doi:10.1111/j.1600-6143.2008.02227.x.
18. Fiel MI, Sauter B, Wu HS, Rodriguez-Laiz G, Gondolesi G, Iyer K, Schiano TD. Regression of hepatic fibrosis after intestinal transplantation in total parenteral nutrition liver disease. Clin Gastroenterol Hepatol 2008;6:926-933. doi:10.1016/j.cgh.2008.04.011.
19. Fishbein TM, Gondolesi GE, Kaufman SS. Intestinal transplantation for gut failure. Gastroenterology 2003;124:1615-1162. doi:10.1016/S0016-5085(03)00375-5.
20. Dahab GM, Kheriza MM, El-Beltagi HM, et al. Digital quantification of fibrosis in liver biopsy sections: description of a new method by Photoshop software. J Gastroenterol Hepatol 2004;19:78-85. doi:10.1111/j.1440-1746.2004.03183.x.
21. Masseroli M, Caballero T, O'Valle F, et al. Automatic quantification of liver fibrosis: design and validation of a new image analysis method: comparison with semi-quantitative indexes of fibrosis. J Hepatol 2000;32:453-464. doi:10.1016/S0168-8278(00)80397-9.
22. Wu HS, Fiel MI, Schiano TD, Gil J. Segmentation of degree of fibrosis from hepatic lobules and portal tracts. J Microsc 2008;231:70-80. doi:10.1111/j.1365-2818.2008.02018.x.
23. Kleiner DE, Brunt EM, van Natta M, Behling C, Contos MJ, Cummings OW, Ferrell LD, Liu YC, Torbenson MS, Unalp-Arida A, Yeh M, McCullough AJ, Sanyal AJ, Nonalcoholic Steatohepatitis Clinical Research Network. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005;41:1313-1321. doi:10.1002/hep.20701.
24. Bedossa P, Dargere D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 2003;38:1449-1457.
25. Carter BA, Shulman RJ. Mechanisms of disease: uptake on the molecular etiology and fundamentals of parenteral nutrition associated cholestasis. Nat Clin Pract Gastroenterol Hepatol 2007;4:277-287. doi:10.1038/ncpgasthep0796.
26. Wanless IR, Nakashima E, Sherman M. Regression of human cirrhosis. Morphologic features and the genesis of incomplete septal cirrhosis. Arch Pathol Lab Med 2000;124:1599-1607.